The DOI matches its Crossref record; 305 of the 305 references it cites were found in a registry or an index.
α-Synuclein misfolding and aggregation: Implications in Parkinson’s disease pathogenesis
Abstract
α-Synuclein (α-Syn) has been extensively studied for its structural and biophysical properties owing to its pathophysiological role in Parkinson's disease (PD). Lewy bodies and Lewy neurites are the pathological hallmarks of PD and contain α-Syn aggregates as their major component. It was therefore hypothesized that α-Syn aggregation is actively associated with PD pathogenesis. The central role of α-Syn aggregation in PD is further supported by the identification of point mutations in α-Syn protein associated with rare familial forms of PD. However, the correlation between aggregation propensities of α-Syn mutants and their association with PD phenotype is not straightforward. Recent evidence suggested that oligomers, formed during the initial stages of aggregation, are the potent neurotoxic species causing cell death in PD. However, the heterogeneous and unstable nature of these oligomers limit their detailed characterization. α-Syn fibrils, on the contrary, are shown to be the infectious agents and propagate in a prion-like manner. Although α-Syn is an intrinsically disordered protein, it exhibits remarkable conformational plasticity by adopting a range of structural conformations under different environmental conditions. In this review, we focus on the structural and functional aspects of α-Syn and role of potential factors that may contribute to the underlying mechanism of synucleinopathies. This information will help to identify novel targets and develop specific therapeutic strategies to combat Parkinson's and other protein aggregation related neurodegenerative diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
Items 201–305 of 305
Clinical overview of the synucleinopathies
Mart�, M. J., Tolosa, E., & Campdelacreu, J. (2003) · Movement Disorders · doi:10.1002/mds.10559 · Cited by 203
How Epigallocatechin Gallate Can Inhibit α-Synuclein Oligomer Toxicity in Vitro
Lorenzen, N., Nielsen, S. B., Yoshimura, Y., Vad, B. S., Andersen, C. B., Betzer, C., Kaspersen, J. D., Christiansen, G., Pedersen, J. S., Jensen, P. H., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.554667 · Cited by 202
Scrapie Produced Experimentally in Goats With Special Reference To the Clinical Syndrome
Pattison, I. H., & Millson, G. C. (1961) · Journal of Comparative Pathology and Therapeutics · doi:10.1016/s0368-1742(61)80013-1 · Cited by 201
Cellular Polyamines Promote the Aggregation of α-Synuclein
Antony, T., Hoyer, W., Cherny, D., Heim, G., Jovin, T. M., & Subramaniam, V. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208249200 · Cited by 200
Kuwahara, T., Koyama, A., Gengyo-Ando, K., Masuda, M., Kowa, H., Tsunoda, M., Mitani, S., & Iwatsubo, T. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m504860200 · Cited by 200
Lewy body cortical involvement may not always predict dementia in Parkinson's disease
Colosimo, C. (2003) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.74.7.852 · Cited by 200
Jacob, R. S., Ghosh, D., Singh, P. K., Basu, S. K., Jha, N. N., Das, S., Sukul, P. K., Patil, S., Sathaye, S., Kumar, A., et al. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.03.002 · Cited by 198
Self-citationAn overview of human prion diseases
Imran, M., & Mahmood, S. (2011) · Virology Journal · doi:10.1186/1743-422x-8-559 · Cited by 197
The prodromal phase of sporadic Parkinson's disease: Does it exist and if so how long is it?
Hawkes, C. H. (2008) · Movement Disorders · doi:10.1002/mds.22242 · Cited by 192
Protein disorder, prion propensities, and self-organizing macromolecular collectives
Malinovska, L., Kroschwald, S., & Alberti, S. (2013) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2013.01.003 · Cited by 191
The Parkinson’s Disease-Associated H50Q Mutation Accelerates α-Synuclein Aggregation in Vitro
Ghosh, D., Mondal, M., Mohite, G. M., Singh, P. K., Ranjan, P., Anoop, A., Ghosh, S., Jha, N. N., Kumar, A., & Maji, S. K. (2013) · Biochemistry · doi:10.1021/bi400999d · Cited by 190
Self-citationFamilial Mutants of α-Synuclein with Increased Neurotoxicity Have a Destabilized Conformation
Bertoncini, C. W., Fernandez, C. O., Griesinger, C., Jovin, T. M., & Zweckstetter, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c500288200 · Cited by 187
Uversky, V. N., Lee, H.-J., Li, J., Fink, A. L., & Lee, S.-J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100551200 · Cited by 186
Protein fibers as performance proteins: new technologies and applications
Scheibel, T. (2005) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2005.05.005 · Cited by 184
Nanomaterials: amyloids reflect their brighter side
Mankar, S., Anoop, A., Sen, S., & Maji, S. K. (2011) · Nano Reviews · doi:10.3402/nano.v2i0.6032 · Cited by 184
Self-citationSolvent-induced collapse of α-synuclein and acid-denatured cytochrome c
Pielak, G. J., Morar, A. S., Olteanu, A., & Young, G. B. (2020) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/wshb-5d82 · Cited by 184
Contribution of somal Lewy bodies to neuronal death
Tompkins, M. M., & Hill, W. D. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00874-3 · Cited by 183
Metal-Catalyzed Oxidation of α-Synuclein in the Presence of Copper(II) and Hydrogen Peroxide
Paik, S. R., Shin, H.-J., & Lee, J.-H. (2000) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2000.1822 · Cited by 180
Structural Characteristics of α-Synuclein Oligomers Stabilized by the Flavonoid Baicalein
Hong, D.-P., Fink, A. L., & Uversky, V. N. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.08.039 · Cited by 177
Ca2+ Binding to α-Synuclein Regulates Ligand Binding and Oligomerization
Nielsen, M. S., Vorum, H., Lindersson, E., & Jensen, P. H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101181200 · Cited by 176
α-synuclein aggregation and its modulation
Ghosh, D., Mehra, S., Sahay, S., Singh, P. K., & Maji, S. K. (2017) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2016.10.021 · Cited by 175
Self-citationFrigerio, R., Fujishiro, H., Ahn, T.-B., Josephs, K. A., Maraganore, D. M., DelleDonne, A., Parisi, J. E., Klos, K. J., Boeve, B. F., Dickson, D. W., et al. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.05.019 · Cited by 173
Stimulation of breast cancer invasion and metastasis by synuclein gamma.
Jia, T., Liu, Y. E., Liu, J., & Shi, Y. E. (1999) · PubMed · Cited by 171
The prion strain phenomenon: Molecular basis and unprecedented features
Morales, R., Abid, K., & Soto, C. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.12.006 · Cited by 171
NAKAJO, S., TSUKADA, K., OMATA, K., NAKAMURA, Y., & NAKAYA, K. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb18337.x · Cited by 170
Rapid Self-assembly of α-Synuclein Observed by In Situ Atomic Force Microscopy
Hoyer, W., Cherny, D., Subramaniam, V., & Jovin, T. M. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.04.051 · Cited by 170
Prions: health scare and biological challenge
Aguzzi, A., Montrasio, F., & Kaeser, P. S. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35052063 · Cited by 168
Lowe, R., Pountney, D. L., Jensen, P. H., Gai, W. P., & Voelcker, N. H. (2004) · Protein Science · doi:10.1110/ps.04879704 · Cited by 165
Structural and Functional Implications of C-Terminal Regions of α-Synuclein
Kim, T. D., Paik, S. R., & Yang, C.-H. (2002) · Biochemistry · doi:10.1021/bi026284c · Cited by 162
Iwata, A. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg283 · Cited by 159
Ghosh, D., Sahay, S., Ranjan, P., Salot, S., Mohite, G. M., Singh, P. K., Dwivedi, S., Carvalho, E., Banerjee, R., Kumar, A., et al. (2014) · Biochemistry · doi:10.1021/bi5010365 · Cited by 158
Self-citationIn vivo silencing of alpha-synuclein using naked siRNA
Lewis, J. M., Melrose, H. L., Bumcrot, D. A., Hope, A. D., Zehr, C., Lincoln, S., Braithwaite, A. T., He, Z., Ogholikhan, S., Hinkle, K. M., et al. (2008) · Molecular Neurodegeneration · doi:10.1186/1750-1326-3-19 · Cited by 157
Crowther, R. A., Daniel, S. E., & Goedert, M. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01440-3 · Cited by 155
Pluripotent stem cell-based therapy for Parkinson’s disease: Current status and future prospects
Sonntag, K., Song, B., Lee, N., Jung, J. H., Cha, Y., Leblanc, P. R., Neff, C., Kong, S. W., Carter, B. S., Schweitzer, J., et al. (2018) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2018.04.005 · Cited by 154
Nath, S., Meuvis, J., Hendrix, J., Carl, S. A., & Engelborghs, Y. (2010) · Biophysical Journal · doi:10.1016/j.bpj.2009.12.4290 · Cited by 149
Homozygous alpha-synuclein p.A53V in familial Parkinson's disease
Yoshino, H., Hirano, M., Stoessl, A. J., Imamichi, Y., Ikeda, A., Li, Y., Funayama, M., Yamada, I., Nakamura, Y., Sossi, V., et al. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.05.022 · Cited by 148
Unique copper‐induced oligomers mediate alpha‐synuclein toxicity
Wright, J. A., Wang, X., & Brown, D. R. (2009) · The FASEB Journal · doi:10.1096/fj.09-130039 · Cited by 147
Engineered and designed peptide-based fibrous biomaterials
MacPhee, C. E., & Woolfson, D. N. (2004) · Current Opinion in Solid State and Materials Science · doi:10.1016/j.cossms.2004.01.010 · Cited by 146
An overview of animal prion diseases
Imran, M., & Mahmood, S. (2011) · Virology Journal · doi:10.1186/1743-422x-8-493 · Cited by 142
Lee, J. C., Langen, R., Hummel, P. A., Gray, H. B., & Winkler, J. R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407307101 · Cited by 141
The small heat shock protein Hsp27 binds α-synuclein fibrils, preventing elongation and cytotoxicity
Cox, D., Whiten, D. R., Brown, J. W. P., Horrocks, M. H., Gil, R. S., Dobson, C. M., Klenerman, D., van Oijen, A. M., & Ecroyd, H. W. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.813865 · Cited by 140
Structure–activity relationship of amyloid fibrils
Maji, S. K., Wang, L., Greenwald, J., & Riek, R. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.07.003 · Cited by 136
Self-citationZhou, W., Schaack, J. B., Zawada, W. M., & Freed, C. R. (2002) · Brain Research · doi:10.1016/s0006-8993(01)03292-9 · Cited by 129
Sato, H., Kato, T., & Arawaka, S. (2013) · Reviews in the Neurosciences · doi:10.1515/revneuro-2012-0071 · Cited by 126
Pasławski, W., Mysling, S., Thomsen, K., Jørgensen, T. J. D., & Otzen, D. E. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201400491 · Cited by 126
Pan, Z., Bruening, W., Giasson, B. I., Lee, V. M. ‐., & Godwin, A. K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201650200 · Cited by 125
Tryptophan Fluorescence Reveals Structural Features of α-Synuclein Oligomers
van Rooijen, B. D., van Leijenhorst-Groener, K. A., Claessens, M. M. A. E., & Subramaniam, V. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.10.021 · Cited by 123
Single-Molecule Imaging of Individual Amyloid Protein Aggregates in Human Biofluids
Horrocks, M. H., Lee, S. F., Gandhi, S., Magdalinou, N. K., Chen, S. W., Devine, M. J., Tosatto, L., Kjærgaard, M., Beckwith, J. S., Zetterberg, H., et al. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00324 · Cited by 121
Genetics of Parkinson's disease and biochemical studies of implicated gene products
Lansbury, P. T., & Brice, A. (2002) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(02)00302-7 · Cited by 120
Characterization of Hydrophobic Residue Requirements for α-Synuclein Fibrillization
Waxman, E. A., Mazzulli, J. R., & Giasson, B. I. (2009) · Biochemistry · doi:10.1021/bi900539p · Cited by 119
Heparan sulfate mediates amyloid-beta internalization and cytotoxicity
Sandwall, E., O'Callaghan, P. W., Zhang, X., Lindahl, U., Lannfelt, L., & Li, J. (2010) · Glycobiology · doi:10.1093/glycob/cwp205 · Cited by 116
G2019S LRRK2 mutation causing Parkinson's disease without Lewy bodies
Gaig, C., Martı́, M. J., Ezquerra, M., Rey, M. J., Cardozo, A., & TOLOSA, E. S. (2007) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2006.107904 · Cited by 112
Bertoncini, C. W., Rasia, R. M., Lamberto, G. R., Binolfi, A., Zweckstetter, M., Griesinger, C., & Fernández, C. O. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.07.009 · Cited by 110
Liu, Y.-Q., Carver, J., Calabrese, A., & Pukala, T. (2014) · Biochimica et Biophysica Acta · doi:10.1016/j.bbapap.2014.04.013 · Cited by 110
Guerrero‐Munoz, M. J., Castillo‐Carranza, D. L., & Kayed, R. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.12.023 · Cited by 110
Genetic neuropathology of Parkinson's disease.
Cookson, M., Hardy, J., & Lewis, P. A. (2008) · PubMed Central · Cited by 108
Purification and Characterization of a Novel Brain‐Specific 14‐kDa Protein
Nakajo, S., Omata, K., Aiuchi, T., Shibayama, T., Okahashi, I., Ochiai, H., Nakai, Y., Nakaya, K., & Nakamura, Y. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb05792.x · Cited by 108
E46K Parkinson’s-Linked Mutation Enhances C-Terminal-to-N-Terminal Contacts in α-Synuclein
Rospigliosi, C. C., McClendon, S., Schmid, A. W., Ramlall, T. F., Barré, P., Lashuel, H. A., & Eliezer, D. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.03.065 · Cited by 102
Pham, C. L. L., Leong, S. L., Ali, F. E. A., Kenche, V. B., Hill, A. F., Gras, S. L., Barnham, K. J., & Cappai, R. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.02.007 · Cited by 100
Heise, H., Celej, M. S., Becker, S., Riedel, D., Pelah, A., Kumar, A., Jovin, T. M., & Baldus, M. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.05.026 · Cited by 100
Khuwaja, G., Khan, M. M., Ishrat, T., Ahmad, A., Raza, S. S., Ashafaq, M., Javed, H., Khan, M. B., Khan, A., Vaibhav, K., et al. (2010) · Brain Research · doi:10.1016/j.brainres.2010.10.023 · Cited by 95
The structure of dopamine induced α-synuclein oligomers
Rekas, A., Knott, R. B., Sokolova, A. V., Barnham, K. J., Perez, K. A., Masters, C. L., Drew, S. C., Cappai, R., Curtain, C. C., & Pham, C. L. L. (2010) · European Biophysics Journal · doi:10.1007/s00249-010-0595-x · Cited by 95
Pasławski, W., Mysling, S., Thomsen, K., Jørgensen, T. J. D., & Otzen, D. E. (2014) · Angewandte Chemie · doi:10.1002/ange.201400491 · Cited by 93
Active immunization therapies for Parkinson's disease and multiple system atrophy
Schneeberger, A., Tierney, L., & Mandler, M. (2015) · Movement Disorders · doi:10.1002/mds.26377 · Cited by 89
Characterization of α-Synuclein Interactions with Selected Aggregation-Inhibiting Small Molecules
Rao, J. N., Dua, V., & Ulmer, T. S. (2008) · Biochemistry · doi:10.1021/bi8002378 · Cited by 86
Cografting astrocytes improves cell therapeutic outcomes in a Parkinson’s disease model
Song, J. J., Oh, S.-M., Kwon, O., Wulansari, N., Lee, H., Chang, M., Lee, E., Sun, W., Lee, S., Chang, S., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci93924 · Cited by 86
Inaba, S., Li, C., Shi, Y. E., et al. (2005) · Breast Cancer Research and Treatment · doi:10.1007/s10549-005-6938-0 · Cited by 84
Cell Adhesion on Amyloid Fibrils Lacking Integrin Recognition Motif
Jacob, R. S., George, E., Singh, P. K., Salot, S., Arunagiri, A., Jha, N. N., Sen, S., & Maji, S. K. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.678177 · Cited by 80
Self-citationThirunavukkuarasu, S., Jares-Erijman, E. A., & Jovin, T. M. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.03.034 · Cited by 77
Widespread and abundant α‐synuclein pathology in a neurologically unimpaired subject
Parkkinen, L., Pirttilä, T., Tervahauta, M., & Alafuzoff, I. I. (2005) · Neuropathology · doi:10.1111/j.1440-1789.2005.00644.x · Cited by 77
Rasool, S., Martínez‐Coria, H., Wu, J., LaFerla, F. M., & Glabe, C. G. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12305 · Cited by 76
Mehra, S., Ghosh, D., Kumar, R., Mondal, M., Gadhe, L. G., Das, S., Arunagiri, A., Jha, N. N., Jacob, R. S., Chatterjee, D., et al. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.004267 · Cited by 74
Self-citationYavich, L., Jäkälä, P., & Tanila, H. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04098.x · Cited by 73
Comparison of α-Synuclein Fibril Inhibition by Four Different Amyloid Inhibitors
Jha, N. N., Kumar, R., Panigrahi, R., Navalkar, A., Ghosh, D., Sahay, S., Mondal, M., Kumar, A., & Maji, S. K. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00261 · Cited by 70
Self-citationβ‐synuclein aggregates and induces neurodegeneration in dopaminergic neurons
Taschenberger, G., Tolö, J., Tereshchenko, J., Akerboom, J., Wales, P., Benz, R., Becker, S., Outeiro, T. F., Looger, L. L., Bähr, M., et al. (2013) · Annals of Neurology · doi:10.1002/ana.23905 · Cited by 69
Effect of curcumin analogs onα-synuclein aggregation and cytotoxicity
Jha, N. N., Ghosh, D., Das, S., Arunagiri, A., Jacob, R. S., Singh, P. K., Ayyagari, N., Namboothiri, I. N. N., & Maji, S. K. (2016) · Scientific Reports · doi:10.1038/srep28511 · Cited by 68
Self-citationStructural Comparison of Mouse and Human α-Synuclein Amyloid Fibrils by Solid-State NMR
Lv, G., Kumar, A., Giller, K., Orcellet, M. L., Riedel, D., Fernández, C. O., Becker, S., & Lange, A. (2012) · Journal of Molecular Biology · doi:10.1016/j.jmb.2012.04.009 · Cited by 67
Diversity in the neuropathology of scrapie-like diseases in animals
Fraser, H. (1993) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a072647 · Cited by 67
Kragh, C. L., Ubhi, K. K., Wyss‐Coray, T., & Masliah, E. (2011) · Brain Pathology · doi:10.1111/j.1750-3639.2011.00545.x · Cited by 66
Ranjan, P., & Kumar, A. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00149 · Cited by 59
Proteostasis of α-Synuclein and Its Role in the Pathogenesis of Parkinson’s Disease
Han, D., Zheng, W., Wang, X., & Chen, Z. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00045 · Cited by 58
A closer look at prion strains
Solforosi, L., Milani, M., Mancini, N., Clementi, M., & Burioni, R. (2013) · Prion · doi:10.4161/pri.23490 · Cited by 56
Sahay, S., Ghosh, D., Dwivedi, S., Arunagiri, A., Mohite, G. M., Kombrabail, M. H., Krishnamoorthy, G., & Maji, S. K. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.598607 · Cited by 55
Self-citationMurakami, K., Tokuda, M., Suzuki, T., Irie, Y., Hanaki, M., Izuo, N., Monobe, Y., Akagi, K., Ishii, R., Tatebe, H., et al. (2016) · Scientific Reports · doi:10.1038/srep29038 · Cited by 55
Mysling, S., Betzer, C., Jensen, P. H., & Jørgensen, T. J. D. (2013) · Biochemistry · doi:10.1021/bi4009193 · Cited by 54
Stefanovic, A. N. D., Lindhoud, S., Semerdzhiev, S. A., Claessens, M. M. A. E., & Subramaniam, V. (2015) · Biochemistry · doi:10.1021/bi501369k · Cited by 51
Quantifying Co-Oligomer Formation by α-Synuclein
Iljina, M., Dear, A. J., Garcia, G. A., De, S., Tosatto, L., Flagmeier, P., Whiten, D. R., Michaels, T. C. T., Frenkel, D., Dobson, C. M., et al. (2018) · ACS Nano · doi:10.1021/acsnano.8b03575 · Cited by 51
Dynamics of protein aggregation and oligomer formation governed by secondary nucleation
Michaels, T. C. T., Lazell, H. W., Arosio, P., & Knowles, T. P. J. (2015) · The Journal of Chemical Physics · doi:10.1063/1.4927655 · Cited by 49
Controlled Exposure of Bioactive Growth Factor in 3D Amyloid Hydrogel for Stem Cells Differentiation
Das, S., Kumar, R., Jha, N. N., & Maji, S. K. (2017) · Advanced Healthcare Materials · doi:10.1002/adhm.201700368 · Cited by 47
Self-citationDugger, B. N., Serrano, G. E., Sue, L. I., Walker, D. G., Adler, C. H., Shill, H. A., Sabbagh, M. N., Caviness, J. N., Hidalgo, J., Saxon‐LaBelle, M., et al. (2012) · Journal of Parkinson s Disease · doi:10.3233/jpd-2012-11073 · Cited by 45
Moloney, T. C., Hyland, R., O’Toole, D. P., Paucard, A., Kirik, D., O’Doherty, A., Gorman, A. M., & Dowd, E. (2013) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12200 · Cited by 44
Sahay, S., Ghosh, D., Singh, P. K., & Maji, S. K. (2016) · Current Protein and Peptide Science · doi:10.2174/1389203717666160314151706 · Cited by 44
Self-citationA pH-dependent switch promotes β-synuclein fibril formation via glutamate residues
Moriarty, G. M., Olson, M. P., Atieh, T. B., Janowska, M. K., Khare, S. D., & Baum, J. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.780528 · Cited by 43
Cytotoxic Oligomers and Fibrils Trapped in a Gel‐like State of α‐Synuclein Assemblies
Kumar, R., Das, S., Mohite, G. M., Rout, S. K., Halder, S., Jha, N. N., Ray, S., Mehra, S., Agarwal, V., & Maji, S. K. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201711854 · Cited by 42
Self-citationClinical course of the first Asian family with Parkinsonism related to SNCA triplication
Sekine, T., Kagaya, H., Funayama, M., Li, Y., Yoshino, H., Tomiyama, H., & Hattori, N. (2010) · Movement Disorders · doi:10.1002/mds.23313 · Cited by 40
Mohite, G. M., Dwivedi, S., Das, S., Kumar, R., Paluri, S., Mehra, S., Ruhela, N., Sakunthala, A., Jha, N. N., & Maji, S. K. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00107 · Cited by 36
Self-citationComplexation of amyloid fibrils with charged conjugated polymers.
Ghosh, D., Dutta, P., Chakraborty, C., Singh, P., Arunagiri, A., Jha, N. N., Jacob, R., Mondal, M., Mankar, S., Das, S., et al. (2014) · Langmuir · doi:10.1021/la404739f · Cited by 33
Self-citationMolecular classification of scrapie strains in mice using gene expression profiling
Booth, S. A., Bowman, C., Baumgartner, R., Dolenko, B., Sorensen, G., Robertson, C., Coulthart, M. B., Phillipson, C. S., & Somorjai, R. L. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.10.150 · Cited by 32
Curtain, C. C., Kirby, N. M., Mertens, H. D. T., Barnham, K. J., Knott, R. B., Masters, C. L., Cappai, R., Rekas, A., Kenche, V. B., & Ryan, T. (2014) · Molecular BioSystems · doi:10.1039/c4mb00356j · Cited by 29
Direct Observation of Murine Prion Protein Replication in Vitro
Sang, J. C., Meisl, G., Thackray, A. M., Hong, L., Ponjavic, A., Knowles, T. P. J., Bujdoso, R., & Klenerman, D. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.8b08311 · Cited by 28
Mohite, G. M., Navalkar, A., Kumar, R., Mehra, S., Das, S., Gadhe, L. G., Ghosh, D., Alias, B., Chandrawanshi, V., Ramakrishnan, A., et al. (2018) · Biochemistry · doi:10.1021/acs.biochem.8b00321 · Cited by 27
Self-citationStudy of Alzheimer's Dementia Patients with Parkinsonian Features
Snowden, M. B., Bowen, J. D., Hughes, J. P., & Larson, E. B. (1995) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/089198879500800302 · Cited by 25
Comparison of the 3D structures of mouse and human α-synuclein fibrils by solid-state NMR and STEM
Hwang, S., Fricke, P., Zinke, M., Giller, K., Wall, J. S., Riedel, D., Becker, S., & Lange, A. (2019) · Journal of Structural Biology · doi:10.1016/j.jsb.2018.04.003 · Cited by 22
Jha, N. N., Ranganathan, S., Kumar, R., Mehra, S., Panigrahi, R., Navalkar, A., Ghosh, D., Kumar, A., Padinhateeri, R., & Maji, S. K. (2017) · Biochemistry · doi:10.1021/acs.biochem.7b01090 · Cited by 19
Self-citationSahay, S., Krishnamoorthy, G., & Maji, S. K. (2016) · Methods and Applications in Fluorescence · doi:10.1088/2050-6120/4/4/042002 · Cited by 9
Self-citation
Cited by
α‐Synuclein aggregation nucleates through liquid‐liquid phase separation
Ray, S., Singh, N., Kumar, R., Patel, K., Pandey, S., Datta, D., Mahato, J., Panigrahi, R., Navalkar, A., Mehra, S., et al. (2020) · Nature Chemistry · doi:10.1038/s41557-020-0465-9 · Cited by 863
Self-citationModeling Parkinson’s Disease With the Alpha-Synuclein Protein
Gómez-Benito, M., Granado, N., García-Sanz, P., Michel, A., Dumoulin, M., & Moratalla, R. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00356 · Cited by 437
Molecular mechanisms of ferroptosis and their involvement in brain diseases
Costa, I., Barbosa, D. J., Benfeito, S., Silva, V., Chavarria, D., Borges, F., Remião, F., & Silva, R. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108373 · Cited by 402
Oxidative Stress: Signaling Pathways, Biological Functions, and Disease
Liu, S., Liu, J., Wang, Y., Deng, F., & Deng, Z. (2025) · MedComm · doi:10.1002/mco2.70268 · Cited by 359
Kraemer, W. J., Ratamess, N. A., Hymer, W. C., Nindl, B. C., & Fragala, M. S. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00033 · Cited by 300
Metadata
- Authors
- Mehra, S., Sahay, S., & Maji, S. K.
- Venue
- Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
- Publisher
- Elsevier BV
- Published
- 2019-10
- Volume
- 1867
- Issue
- 10
- Pages
- 890-908
- ISSN
- 1570-9639 (ISSN-L)
- OpenAlex
- W2921561422
- Cited by
- 499
- References
- 305
- FWCI
- 21.29
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.